The case for expanding worldwide access to point of care molecular drug susceptibility testing for isoniazid.
作者信息
Vogensen Vanessa B, Anthony Richard M, Kerstjens Huib A M, Tiberi Simon, de Steenwinkel Jurriaan E M, Akkerman Onno W
机构信息
Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
出版信息
Clin Microbiol Infect. 2022 Aug;28(8):1047-1049. doi: 10.1016/j.cmi.2022.03.033. Epub 2022 Apr 1.
PMID:35378271
Abstract
摘要
Zotero 插件